Delayed Diagnosis and Evolving Trends in Gastric Cancer During and After COVID-19: A Comparative Study of Staging, Helicobacter pylori Infection and Bleeding Risk in Western Romania

<b>Background and Objectives:</b> Gastric cancer (GC) remains a leading cause of cancer mortality worldwide, and the COVID-19 pandemic posed new barriers in diagnosis and management. This study aimed to assess whether pandemic-related healthcare disruptions resulted in more advanced GC stages at presentation. We additionally examined the role of <i>Helicobacter pylori</i> (<i>H. pylori</i>) across non-cardia GC (NCGC) versus cardia GC (CGC) and evaluated the risk factors of upper gastrointestinal (GI) bleeding. <b>Methods:</b> A retrospective cohort of 121 adult patients with GC was enrolled from a tertiary Gastroenterology Unit in Western Romania, spanning pre-pandemic (March 2018-February 2020), pandemic (March 2020-February 2022), and post-pandemic (March 2022-February 2024) periods. Demographic profiles, TNM staging, histopathology, <i>H. pylori</i> status, and clinical outcomes-including GI bleeding-were extracted from medical records. <b>Results:</b> An increase in advanced GC (Stage III-IVB) was noted in the post-pandemic period (69.4% vs. 53.3% pre-pandemic; <i>p</i> = 0.021). <i>H. pylori</i> positivity remained higher in NCGC (70.6%) compared to CGC (44.6%; overall <i>p</i> = 0.041); however, CGC cases showed a rise in <i>H. pylori</i> prevalence post-pandemic (36.4% to 55.6%). One-year mortality was driven by an advanced stage (hazard ratio [HR] = 2.74, <i>p</i> = 0.002), diagnosis during the COVID-19 pandemic (HR = 1.66, <i>p</i> = 0.010), and age ≥70 years (HR = 1.88, <i>p</i> = 0.043). <b>Conclusions:</b> Our findings demonstrate that delayed diagnostic endoscopy correlated with a higher proportion of advanced GC in the post-pandemic phase. <i>H. pylori</i> was strongly linked to NCGC, though CGC showed an increasing trend in <i>H. pylori</i> prevalence. Patients on antithrombotic agents faced increased GI bleeding risks.

Authors

Institutions

Publication Details

Journal
Diagnostics
Published
2025-04-09
DOI
https://doi.org/10.3390/diagnostics15080950
Citations
4
Primary Topic
Helicobacter pylori-related gastroenterology studies
Type
article
Field-Weighted Citation Impact
8.03
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Delayed Diagnosis and Evolving Trends in Gastric Cancer During and After COVID-19: A Comparative Study of Staging, Helicobacter pylori Infection and Bleeding Risk in Western Romania

Renata Fofiu, Giovanni Aragona, Bogdan Miuţescu, Eyad Gadour et al.
4 citations
Diagnostics
Helicobacter pylori-related gastroenterology studies
8.03
article

Delayed Diagnosis and Evolving Trends in Gastric Cancer During and After COVID-19: A Comparative Study of Staging, Helicobacter pylori Infection and Bleeding Risk in Western Romania

Renata Fofiu, Giovanni Aragona, Bogdan Miuţescu, Eyad Gadour, Edward Paul Șeclăman, Ruxandra Mare, Călin Burciu, Roxana Șirli, Patricia Serena, Luca Serena
article en
4 citations

Abstract

<b>Background and Objectives:</b> Gastric cancer (GC) remains a leading cause of cancer mortality worldwide, and the COVID-19 pandemic posed new barriers in diagnosis and management. This study aimed to assess whether pandemic-related healthcare disruptions resulted in more advanced GC stages at presentation. We additionally examined the role of <i>Helicobacter pylori</i> (<i>H. pylori</i>) across non-cardia GC (NCGC) versus cardia GC (CGC) and evaluated the risk factors of upper gastrointestinal (GI) bleeding. <b>Methods:</b> A retrospective cohort of 121 adult patients with GC was enrolled from a tertiary Gastroenterology Unit in Western Romania, spanning pre-pandemic (March 2018-February 2020), pandemic (March 2020-February 2022), and post-pandemic (March 2022-February 2024) periods. Demographic profiles, TNM staging, histopathology, <i>H. pylori</i> status, and clinical outcomes-including GI bleeding-were extracted from medical records. <b>Results:</b> An increase in advanced GC (Stage III-IVB) was noted in the post-pandemic period (69.4% vs. 53.3% pre-pandemic; <i>p</i> = 0.021). <i>H. pylori</i> positivity remained higher in NCGC (70.6%) compared to CGC (44.6%; overall <i>p</i> = 0.041); however, CGC cases showed a rise in <i>H. pylori</i> prevalence post-pandemic (36.4% to 55.6%). One-year mortality was driven by an advanced stage (hazard ratio [HR] = 2.74, <i>p</i> = 0.002), diagnosis during the COVID-19 pandemic (HR = 1.66, <i>p</i> = 0.010), and age ≥70 years (HR = 1.88, <i>p</i> = 0.043). <b>Conclusions:</b> Our findings demonstrate that delayed diagnostic endoscopy correlated with a higher proportion of advanced GC in the post-pandemic phase. <i>H. pylori</i> was strongly linked to NCGC, though CGC showed an increasing trend in <i>H. pylori</i> prevalence. Patients on antithrombotic agents faced increased GI bleeding risks.

DiagnosticsVol. 15(8)
King Fahad Specialist Hospital (SA), Victor Babeș University of Medicine and Pharmacy Timișoara (RO), Vasile Goldis Western University of Arad (RO), Guglielmo da Saliceto Hospital (IT)
Openalex Percentile: Top 3%
Helicobacter pylori-related gastroenterology studies
8.03
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.